Drug dependence potential of viloxazine hydrochloride tested in rhesus monkeys.
The drug dependence potential of viloxazine was tested in 5 experiments on rhesus monkeys. In gross behavioral observation of normal monkeys the acute CNS effects of the drug were found to be very weak. Decrement of spontaneous motor activity and occasional eye-closing were observed with single doses higher than 16 mg/kg IV, IM and 128 mg/kg PO, while convulsions and death occured at 64 mg/kg IV and IM. Viloxazine did not suppress the morphine and barbital withdrawal signs in monkeys that had been made physically dependent on these drugs and withdrawal. In the test for physical dependence by repeated administration of the drug at 16 mg/kg IM twice daily for 31 days in normal monkeys, no observable withdrawal sign was developed in the naloxone precipitation and natural withdrawal tests. In intravenous self-administration experiments, a weak reinforcing effect was demonstrated in some monkeys, but the effect was extremely weak. Thus, viloxazine was found to be physical dependence-free and its overall dependence potential was regarded as very low.
D000818:Animals; D001462:Barbital; D001522:Behavior, Animal / Q000187:drug effects*; D005260:Female; D000882:Haplorhini; D006801:Humans; D008253:Macaca mulatta; D008297:Male; D009021:Morphine Dependence; D009025:Morpholines; D010627:Phenethylamines / Q000008:administration & dosage; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders; D014745:Viloxazine / Q000008:administration & dosage / Q000494:pharmacology
D009025:Morpholines; D010627:Phenethylamines; C011896:lephetamine; D014745:Viloxazine; D001462:Barbital